IQ Capital
Investor profile
Investment firmVenture capital
Also recorded as: IQCapital
Deals
97
distinct rounds
Companies
68
backed
Active span
2009–2026
18 yrs
Total round €
€1.5B
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Parkwalk Advisors9
- Molten Ventures7
- BGF6
- Draper Esprit6
- Notion Capital5
- Amadeus Capital Partners4
- Mercia Ventures4
- AlbionVC3
- British Patient Capital3
- Cambridge Angels3
- Cambridge Enterprise3
- Cambridge Innovation Capital3
- EOS Ventures3
- Longwall Ventures3
- Martlet Capital3
- Meltwind3
- Northern Gritstone3
- Playfair Capital3
- Seedcamp3
- Backed VC2
- Bloc Ventures2
- Creator Fund2
- Dawn Capital2
- Draper Associates2
- Hostplus2
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Thought Machine | UK | 1 | €178M |
| Nyobolt | UK | 4 | €145M |
| Tropic | UK | 1 | €91M |
| Trogenix | UK | 1 | €81M |
| Speechmatics | UK | 2 | €66M |
| GaN Devices | UK | 3 | €56M |
| Paragraf | UK | 1 | €54M |
| Nu Quantum | UK | 1 | €52M |
| IMU Biosciences | UK | 1 | €46M |
| AccelerComm | UK | 3 | €44M |
| Isembard | UK | 1 | €43M |
| causaLens | UK | 1 | €40M |
| CybSafe | UK | 2 | €33M |
| Risilience | UK | 2 | €31M |
| Rivan | UK | 1 | €29M |
| Divido | UK | 2 | €25M |
| CyberSmart | UK | 3 | €22M |
| Gravis Robotics | Switzerland | 1 | €20M |
| Synthesized | UK | 2 | €19M |
| BMLL | UK | 1 | €19M |
| NanoSyrinx | UK | 2 | €19M |
| TurinTech | UK | 1 | €18M |
| Apperio | UK | 3 | €17M |
| Closed Loop Medicine | UK | 2 | €17M |
| Neul | UK | 2 | €16M |
| Optellum | UK | 1 | €15M |
| Opteran | UK | 2 | €14M |
| RevEng.AI | UK | 1 | €13M |
| Neurovalens | Ireland | 2 | €13M |
| Mindgard | UK | 2 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Thought Machine | Series C | €178M | 2021-11 |
| Tropic | Series C | €91M | 2026-03 |
| Trogenix | Series A | €81M | 2025-10 |
| Nyobolt | Other | €59M | 2022-07 |
| Speechmatics | Series B | €59M | 2022-06 |
| Paragraf | Series B | €54M | 2022-03 |
| Nu Quantum | Other | €52M | 2025-12 |
| Nyobolt | Other | €51M | 2026-05 |
| IMU Biosciences | Other | €46M | 2026-06 |
| Isembard | Series A | €43M | 2026-03 |